Catalyst Pharmaceutical Partners Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Catalyst Pharmaceutical Partners

CPRX 21.00

-1.7%

Oct 29 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: DonShimoda	3/4/2012 12:03:49 PM
	of 116

A recent publication in Journal of Medicinal Chemistry points to CPP-115's potential use as a treatment for cocaine addiction. The article highlights CPP-115's pharmacological target specificity and its visual safety when compared with vigabatrin. While this data is pre-clinical, the company is expected to release the first results from its P1 clinical trial in early 2012. catalystpharma.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next